ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Quality Indicators"

  • Abstract Number: 1590 • ACR Convergence 2020

    Bone Health in ANCA – Associated Vasculitis Patients

    Deepa Ragesh Panikkath1, Sandy Lee2 and Christina Downey2, 1Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, 2Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Glucocorticoids (GC) are an important mode of therapy in ANCA associated vasculitis (AAV), and osteoporosis (OP) and fractures are potential adverse effects seen. The…
  • Abstract Number: 1591 • ACR Convergence 2020

    A Quality Improvement Project to Increase Vitamin D Prescribing for Pediatric Patients on Glucocorticoids

    Katherine Kaufman1, Mary Buckley1, Laura Cannon1, Rachel Randell1, Philip Chu1, Mithu Maheswaranathan1, Andrew Johannemann1, D Ryan Anderson1, Isaac Smith1, Akrithi Udupa1 and David Leverenz1, 1Duke University, DURHAM, NC

    Background/Purpose: Chronic glucocorticoid treatment in children increases the risk of bone loss, fractures, and reduced adult skeletal mass. The 2017 ACR Glucocorticoid-Induced Osteoporosis (GIOP) guidelines…
  • Abstract Number: 1596 • ACR Convergence 2020

    Coproduction of Care for Veterans with RA: Improving Elicitation and Documentation of Patient Goals

    Swathi Reddy1, Kyawt Shwin1, Rashmi Arora1, Sarah Homann2, Lisa Johnson3, Yusuf Chao4, Aricca Van Citters3, Brant Oliver5, Guy Eakin6, Eugene Nelson3, Andreas Reimold1 and Salahuddin Kazi1, 1Veterans Affairs North Texas Healthcare System / UT Southwestern Medical Center, Dallas, TX, 2Veterans Affairs Tennessee Valley Healthcare System / Vanderbilt University Medical Center, Nashville, TN, 3The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, 4UT Southwestern Medical Center, Dallas, TX, 5The Dartmouth Institute for Health Policy & Clinical Practice / Veterans Affairs National Quality Scholars Fellowship in Healthcare Quality & Safety, Lebanon, NH, 6Arthritis Foundation, Atlanta, GA

    Background/Purpose: Coproduction of healthcare services offers a pathway to increase patient engagement in care. Patients and clinicians coproduce care by working together to: (1) co-assess…
  • Abstract Number: 1622 • ACR Convergence 2020

    Determining the Zoster Vaccination Rate Among Veterans on Chronic Immunosuppressive Therapy at the Southeast Louisiana Veterans Healthcare System – a Quality Indicator

    Hannah Kenninger1, Rachel Dayno1, Nkechinyere Emejuaiwe2, Ileannette Robledo-Vega3, Whitney Bembry1, Myriam Guevara4 and Soham Mahato5, 1Tulane University School of Medicine, New Orleans, LA, 2Southeast Louisiana Veterans Healthcare System, New Orlenas, LA, 3Louisiana State University Health Sciences Center, New Orlenas, LA, 4Lousiana State University Health Sciences Center, New Orleans, LA, 5LSUHSC School of Public Health, New Orleans, LA

    Background/Purpose: Herpes Zoster (HZ) causes an infection commonly known as shingles. Patients with HZ are at increased risk for post-herpetic neuralgia, which is painful for…
  • Abstract Number: 278 • 2019 ACR/ARP Annual Meeting

    Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting

    Jun Chu1, Elaine Poncio 2, Yenealem Temesgen-Oyelakin 2, Michael Davis 3, Isabel Ochoa-Navas 2, Sarthak Gupta 4, Zerai Manna 2, Marquis Chapman 1, Eileen Chu 5, Aidan Donnellan 6 and Sarfaraz Hasni 7, 1National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, 2NIAMS/NIH, Bethesda, 3NIAMS/NIH, Bethesda, MD, 4Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, 5National Institutes of Health, Derwood, MD, 6National Institutes of Health, Bethesda, 7NIAMS, National Institutes of Health, Bethesda, MD

    Background/Purpose: The care for patients with lupus is complex as they may exhibit multiple concomitant medical and socioeconomic issues. To address all their needs according…
  • Abstract Number: 1192 • 2019 ACR/ARP Annual Meeting

    Effect of a Clinical Decision Support System on a Quality Indicator of Glucocorticoid-induced Osteoporosis and Trends of Drug Treatment in a Japanese Hospital

    Hiroki Ozawa1, Sho Fukui 1, Genki Kidoguchi 1, Takehiro Nakai 2, Satoshi Kawaai 1, Ayako Koido 1, Yukihiko Ikeda 1, Masei Suda 1, Haruyuki Yanaoka 1, Hisanori Shimizu 1, Hiromichi Tamaki 1, Tokutaro Tsuda 1, Mitsumasa Kishimoto 3, Kenichi Yamaguchi 1 and Masato Okada 1, 1St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Japan, 2St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Tokyo, Japan, 3Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan

    Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is a common, preventable and treatable complication of glucocorticoid therapy. We defined quality indicator (QI) for GIOP and took a hospital-wide…
  • Abstract Number: 1178 • 2018 ACR/ARHP Annual Meeting

    Patients’ and Healthcare Professionals’ Resource Preferences for a Knowledge Translation Toolkit for Hip and Knee Replacement Rehabilitation

    Marie Westby1, Cheryl L. Koehn2, Sheila Kerr3 and Alison Hoens4, 1Centre for Hip Health and Mobility, Vancouver, BC, Canada, 2Arthritis Consumer Experts, Vancouver, BC, Canada, 3Patient Advisor, Vancouver, BC, Canada, 4Physical Therapy, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Widely varying rehabilitation practices for total joint replacement (TJR) for hip and knee osteoarthritis (OA) contribute to inconsistent patient outcomes and satisfaction. Informed by…
  • Abstract Number: 2960 • 2018 ACR/ARHP Annual Meeting

    Evaluation of Performance Measures Reveals Delays and Sub-Optimal Access to Rheumatology Care and Treatment

    Claire Barber1, Diane Lacaille2, Peter Faris3, Dianne P. Mosher4, Steven J. Katz5, Joanne Homik6, Jatin Patel7, Sharon Zhang7, Cheryl Barnabe8, Glen Hazlewood9, Vandana Ahluwalia10, Natalie J. Shiff11, Vivian P. Bykerk12, Marinka Twilt13, Susanne Benseler14, Jennifer Burt15 and Deborah A. Marshall16, 1Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Arthritis Research Canada/University of British Columbia, Medicine/Rheumatology, Richmond, BC, Canada, 3Alberta Health Services, Alberta, AB, Canada, 4Med, University of Calgary, Calgary, AB, Canada, 5Rheumatology, University of Alberta, Edmonton, AB, Canada, 6University of Alberta, Edmonton, AB, Canada, 7Alberta Health Services, Calgary, AB, Canada, 8Medicine, University of Calgary, Calgary, AB, Canada, 9Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, 10William Osler Health Center, Brampton, ON, Canada, 11University of Florida, Gainesville, FL, 12Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, 13University of Calgary, Calgary, AB, Canada, 14Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 15St. Clare's Mercy Hospital, Eastern Health, St. John's, NF, Canada, 16Community Health Sciences, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Early diagnosis, treatment and ongoing care are critical to optimize RA outcomes. The purpose of the study was to evaluate key elements of RA…
  • Abstract Number: 1593 • 2017 ACR/ARHP Annual Meeting

    Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan

    Nobuyuki Yajima1, Ken-ei Sada2, Shingo Fukuma3, Yasushi Tsujimoto4, Sayaka Shimizu3, Kakuya Niihata5, Tsuneyo Mimori6, Yoshiya Tanaka7, Tsutomu Takeuchi8, Mayumi Sugiura9, Hitoshi Kohsaka10, Naoto Tamura11, Masataka Kuwana12, Hideto Kameda13, Asano Yoshihide14, Teruhisa Azuma15, Toshihiro Matsui16, Katsuya Suzuki17, Ryo Takahashi1, Shunichi Fukuhara3 and Tatsuya Atsumi18, 1Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan, 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 3Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan, 4Department of Nephrology and Dialysis, Kyoritsu Hospital, Hyogo, Japan, 5Division of Clinical Epidemiology, Fukushima Medical University, FUKUSHIMA, Japan, 6Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 7The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 8Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 9Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical sciences, Nagoya, Japan, 10Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, 11Rheumatology, Juntendo University, Tokyo, Japan, 12Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 13Division of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan, 14Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 15Satellite for Teaching And Research in General Medicine, Fukushima Medical University, Fukushima, Japan, 16Department of Lifetime Clinical Immunology Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 17Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan, 18Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    Background/Purpose: A QI set for systemic lupus erythematosus (SLE) was developed in the United States. However, this does not necessarily conform to the Japanese medical…
  • Abstract Number: 1085 • 2017 ACR/ARHP Annual Meeting

    Application of Lupus Nephritis Quality Measures to Understand Gaps in Care for SLE

    Lisa Gaynon1, Maria Dall'Era2, Patricia P. Katz2, Lindsey A. Criswell2, Cristina Lanata2, Laura Trupin3, Charles G. Helmick4 and Jinoos Yazdany3, 1Internal Medicine, California Pacific Medical Center, San Francisco, CA, 2Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 4Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose: In 2012, the ACR released guidelines for monitoring and treatment of lupus nephritis (LN), but studies have yet to evaluate adherence to these recommendations.…
  • Abstract Number: 21 • 2017 Pediatric Rheumatology Symposium

    Enhancing Quality of Care in Childhood-Onset Systemic Lupus Erythematosus by Improving Performance on Quality Indicator Measures in Cardiovascular and Bone Health

    Emily A. Smitherman1, Adam Furnier2, Janalee Taylor3, Mary Beth Burns4, Hermine Brunner5 and Esi Morgan1, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Rheumatology, PRCSG, Cincinnati, OH

    Background/Purpose: Childhood-onset SLE (cSLE) leads to poor health outcomes, including cardiovascular and bone health, due to high rates of potentially devastating disease complications and medication…
  • Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting

    Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis

    Matthew Cooper1 and Claire E H Barber2, 1University of Calgary, Calgary, AB, Canada, 2Rheumatology, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…
  • Abstract Number: 2247 • 2016 ACR/ARHP Annual Meeting

    REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States

    Bruce Kirkham1, Estee Chan2, Alexandra Vincent2 and Alison Elliott3, 1Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, 2Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, 3Market Access Directorate, Roche Products LTD UK, Welwyn Garden City, United Kingdom

    Background/Purpose: Rheumatoid Arthritis (RA) has differing therapeutic outcomes, with resulting differences in function and quality of life. Little is known about the effects of disease…
  • Abstract Number: 368 • 2015 ACR/ARHP Annual Meeting

    The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital

    Masei Suda1, Masato Okada1, Yasuhiro Suyama2, Mitsumasa Kishimoto1 and Tokutaro Tsuda1, 1Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 2Rheumatology, JR Tokyo General Hospital, Tokyo, Japan

    Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is one of the most clinically significant side effects of glucocorticoid use, and the prevention of GIOP has become more important…
  • Abstract Number: 999 • 2015 ACR/ARHP Annual Meeting

    Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation

    Marie Westby1, Deborah Marshall2, Jane Squire Howden3 and C. Allyson Jones4, 1School of Public Health, University of Alberta, Edmonton, AB, Canada, 2University of Calgary, Calgary, AB, Canada, 3Edmonton Musculoskeletal Centre, Edmonton, AB, Canada, 4Physical Therapy, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Rehabilitation before and after total hip (THA) and knee arthroplasty (TKA) surgery has been shown to decrease pain and impairment, and improve mobility, activity…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology